Clinical Service Center

What Clinical Service Center does

Clinical Service Center (CSC) is a privately-held, China-based full-service Contract Research Organization founded in 2009, headquartered in Suzhou within the Jiangsu Free Trade Pilot Zone with an additional Beijing office, 20+ domestic offices across China, and 10+ global offices. The company serves global biopharmaceutical and medical device enterprises, authoritative academic institutions, clinical trial research institutions, and medical experts, providing end-to-end clinical development services spanning therapeutic areas including Oncology, Respiratory, Neurology, Ophthalmology, Infectious Disease, Endocrinology, Immunology, and Pain. CSC also offers licensing transaction support through an affiliated entity, Bio-link Capital.

CSC operates an integrated service stack of 11 modules anchored on three core pillars — Clinical Operations, Regulatory Affairs, and Medical Affairs — complemented by Data Management and Statistical Analysis (delivered through its "Meta-Clinical" platform), Medical and Clinical Strategy, Pharmacovigilance and Call Center, Quality Assurance and Audits, Site and Patient Management, a Phase I Unit, Global Business Affairs, and In/Out Licensing Services. The company claims 2,000+ domestic clinical trials and 100+ global clinical trials completed, with a 1,000+ global employee base. In August 2024, CSC acquired Jiangsu Pu Er Jing Biopharmaceutical Co., Ltd., adding mass spectrometry detection and bioanalytical laboratory capability.

CSC's commercial model is a sales-led, professional services B2B engagement, with project-based pricing negotiated per contract and no public pricing disclosed. Leadership is concentrated in three co-founders — Chairman/CSO Dr. Daniel Liu (ICH-E6 R3 expert, ex-Novartis/Pfizer/Sanofi), CEO Mr. Yu Xu (22 years pharma industry), and CSO Dr. A.S. Hualong Sun (25+ years, ex-Merck Serono/PAREXEL) — supplemented by senior VPs from Johnson & Johnson, Roche, Takeda, and other major pharma, underpinning the company's credibility with global sponsors. CSC is privately held with no disclosed funding rounds, no public listing, and no disclosed revenue.

Name

Clinical Service Center

Legal name

Clinical Service Center Co., Ltd.

Website

https://clinicservicecenter.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Clinical Service Center is a privately-held, China-based full-service Contract Research Organization founded in 2009, providing clinical operations, regulatory affairs, medical affairs, and bioanalytical services to global biopharmaceutical and medical device companies across eight therapeutic areas.

Ownership category

akta.pro rank

Headquarters

HQ city

Suzhou

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Research Services: Full-service CRO providing comprehensive clinical trials services including clinical operations, regulatory affairs, medical writing, statistical analysis, data management, pharmacovigilance, call center, quality assurance, training and consulting.
2. Regulatory Affairs Services: Comprehensive registration strategies covering the whole lifecycle of project implementation and regulatory consultation services.
3. Medical Affairs Services: Medical monitoring, medical strategy and writing services provided by clinical medical professionals with many years of clinical work experience.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Clinical Service Center is a full-service Contract Research Organization (CRO) delivering clinical trial management and related services for global biopharmaceutical and medical device enterprises. Its core offerings span Clinical Operations, Regulatory Affairs, Medical Affairs, Data Management & Statistical Analysis (via the Meta-Clinical platform), Pharmacovigilance and Call Center, Quality Assurance & Audits, Medical & Clinical Strategy, Site & Patient Management, Phase I Unit, Global Business Affairs, and In/Out Licensing Services. The company supports therapeutic areas including Oncology, Respiratory, Neurology, Ophthalmology, Infectious Disease, Endocrinology, Immunology, and Pain management.

Product overview

Clinical Service Center is a full-service Contract Research Organization (CRO) providing comprehensive clinical trials services through an integrated platform of 11 distinct service modules. The core offerings center on three primary pillars: Clinical Operations, Regulatory Affairs, and Medical Affairs, supported by specialized services including Data Management & Statistical Analysis (via Meta-Clinical), Pharmacovigilance and Call Center, Quality Assurance & Audits, Site & Patient Management, Phase I Unit, Global Business Affairs, and In/Out Licensing Services (through Bio-link Capital). The organization serves global biopharmaceutical and medical device companies with therapeutic expertise spanning Oncology, Respiratory, Neurology, Ophthalmology, Infectious Disease, Endocrinology, Immunology, and Pain management.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 2000+ domestic clinical trials completed
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Medpace Holdings: Mid-sized global full-service CRO focused on small-to-mid-cap biopharma with strong therapeutic expertise. Comparable in offering structure (full-service clinical development) and target customer segment, though primarily US-centric.
• Pharmaron: China-based integrated CRO/CDMO offering laboratory, clinical and regulatory services. Directly comparable as a similarly positioned Chinese-headquartered CRO competing for both inbound and outbound trial business; useful scale and capability benchmark.
• Hangzhou Tigermed: Leading Chinese full-service CRO offering clinical operations, biostatistics, regulatory and pharmacovigilance services globally. Directly comparable as a China-based full-service CRO competing for both domestic Chinese trials and international studies; a key benchmark for CSC's scale-up trajectory.

Broad incumbents

• PAREXEL International: Global full-service CRO with deep biostatistics and clinical operations capabilities. CSC's co-founder Dr. Hualong Sun previously headed data and clinical operations at PAREXEL, signaling operational similarity; competes with CSC for international study awards.
• ICON plc: Global CRO with broad clinical, bioanalytical and laboratory services including post-PRA Health acquisition. Comparable as a mid-to-large full-service CRO alternative for sponsor outsourcing decisions overlapping with CSC's value proposition.
• WuXi AppTec: China-headquartered global CRO/CDMO offering end-to-end discovery, development and clinical services. Overlaps with CSC across clinical operations and regulatory affairs but operates at vastly larger scale with broader service breadth; useful as a broad-incumbent benchmark.
• Labcorp Drug Development (Fortrea): Spin-off clinical CRO from Labcorp offering Phase I-IV clinical, bioanalytical and central lab services globally. Broad-incumbent peer with overlapping capabilities in clinical operations, bioanalytical and central laboratory services.
• IQVIA: Largest global CRO and life sciences data company offering clinical, commercial and real-world evidence services. Represents the upper bound of scale and competition CSC faces on large, multi-country Phase II/III programs.

Emerging players

• Frontage Laboratories: US-listed CRO/CDMO with bioanalytical and clinical research services and a strong footprint in China. Comparable through its bioanalytical/central lab capabilities - directly relevant given CSC's Jiangsu Pu Er Jing mass spectrometry acquisition.
• Novotech (Novotech Health Holdings): Asia-Pacific focused mid-sized CRO with strong presence in China and Australia. Comparable as a regional mid-sized CRO pursuing global sponsor business, with similar therapeutic-area focus on oncology and infectious disease.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/clinical-service-center

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Service Center